Segmental early enhancement defect ( a measure of scar size ) was reduced by TESI in both injected ( -43.7 4.4 % ; n = 95 ; P < 0.01 ) and noninjected segments ( -25.1 7.8 % ; n = 148 ; P < 0.001 ; between-group comparison P < 0.05 ) .